{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:25:15Z","timestamp":1707524715061},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,11,15]]},"DOI":"10.7759\/cureus.31531","type":"journal-article","created":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T13:10:40Z","timestamp":1668517840000},"source":"Crossref","is-referenced-by-count":0,"title":["Utility of Gadolinium Use in the Imaging Follow-Up of Nonenhancing Primary Brain Neoplasms in Children"],"prefix":"10.7759","author":[{"given":"Tiagpaul","family":"Bhamber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zereen","family":"Sarwar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yekaterina","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brittany K","family":"Albers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chetan","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13718","article-title":"Gadolinium deposition and the potential for toxicological sequelae: a literature review of issues surrounding gadolinium-based contrast agents","volume":"84","author":"Layne KA","year":"2018","unstructured":"Layne KA, Dargan PI, Archer JR, Wood DM. Gadolinium deposition and the potential for toxicological sequelae: a literature review of issues surrounding gadolinium-based contrast agents. Br J Clin Pharmacol. 2018, 84:2522-34. 10.1111\/bcp.13718","journal-title":"Br J Clin Pharmacol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mri.2016.08.017","article-title":"Gadolinium based contrast agents (GBCA): safety overview after 3 decades of clinical experience","volume":"34","author":"Kanal E","year":"2016","unstructured":"Kanal E. Gadolinium based contrast agents (GBCA): safety overview after 3 decades of clinical experience. Magn Reson Imaging. 2016, 34:1341-5. 10.1016\/j.mri.2016.08.017","journal-title":"Magn Reson Imaging"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1039\/b905145g","article-title":"Incorporation of excess gadolinium into human bone from medical contrast agents","volume":"1","author":"Darrah TH","year":"2009","unstructured":"Darrah TH, Prutsman-Pfeiffer JJ, Poreda RJ, Ellen Campbell M, Hauschka PV, Hannigan RE. Incorporation of excess gadolinium into human bone from medical contrast agents. Metallomics. 2009, 1:479-88. 10.1039\/b905145g","journal-title":"Metallomics"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00247-017-3806-0","article-title":"Gadolinium-based contrast agents in pediatric magnetic resonance imaging","volume":"47","author":"Gale EM","year":"2017","unstructured":"Gale EM, Caravan P, Rao AG, McDonald RJ, Winfeld M, Fleck RJ, Gee MS. Gadolinium-based contrast agents in pediatric magnetic resonance imaging. Pediatr Radiol. 2017, 47:507-21. 10.1007\/s00247-017-3806-0","journal-title":"Pediatr Radiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s00247-021-04973-5","article-title":"Gadolinium retention: should pediatric radiologists be concerned, and how to frame conversations with families","volume":"52","author":"Noda SM","year":"2022","unstructured":"Noda SM, Oztek MA, Stanescu AL, Maloney E, Shaw DW, Iyer RS. Gadolinium retention: should pediatric radiologists be concerned, and how to frame conversations with families. Pediatr Radiol. 2022, 52:345-53. 10.1007\/s00247-021-04973-5","journal-title":"Pediatr Radiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3109\/02841851.2010.515614","article-title":"Gadolinium released from MR contrast agents is deposited in brain tumors: in situ demonstration using scanning electron microscopy with energy dispersive x-ray spectroscopy","volume":"51","author":"Xia D","year":"2010","unstructured":"Xia D, Davis RL, Crawford JA, Abraham JL. Gadolinium released from MR contrast agents is deposited in brain tumors: in situ demonstration using scanning electron microscopy with energy dispersive x-ray spectroscopy. Acta Radiol. 2010, 51:1126-36. 10.3109\/02841851.2010.515614","journal-title":"Acta Radiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/RLI.0000000000000072","article-title":"Progressive increase of T1 signal intensity of the dentate nucleus on unenhanced magnetic resonance images is associated with cumulative doses of intravenously administered gadodiamide in patients with normal renal function, suggesting dechelation","volume":"49","author":"Errante Y","year":"2014","unstructured":"Errante Y, Cirimele V, Mallio CA, Di Lazzaro V, Zobel BB, Quattrocchi CC. Progressive increase of T1 signal intensity of the dentate nucleus on unenhanced magnetic resonance images is associated with cumulative doses of intravenously administered gadodiamide in patients with normal renal function, suggesting dechelation. Invest Radiol. 2014, 49:685-90. 10.1097\/RLI.0000000000000072","journal-title":"Invest Radiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s00247-019-04535-w","article-title":"Brain tissue gadolinium retention in pediatric patients after contrast-enhanced magnetic resonance exams: pathological confirmation","volume":"50","author":"Stanescu AL","year":"2020","unstructured":"Stanescu AL, Shaw DW, Murata N, Murata K, Rutledge JC, Maloney E, Maravilla KR. Brain tissue gadolinium retention in pediatric patients after contrast-enhanced magnetic resonance exams: pathological confirmation. Pediatr Radiol. 2020, 50:388-96. 10.1007\/s00247-019-04535-w","journal-title":"Pediatr Radiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.mri.2016.08.024","article-title":"Gadolinium deposition in the brain","volume":"34","author":"Kanda T","year":"2016","unstructured":"Kanda T, Nakai Y, Oba H, Toyoda K, Kitajima K, Furui S. Gadolinium deposition in the brain. Magn Reson Imaging. 2016, 34:1346-50. 10.1016\/j.mri.2016.08.024","journal-title":"Magn Reson Imaging"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3348\/kjr.2018.0356","article-title":"Gadolinium deposition in the brain: current updates","volume":"20","author":"Choi JW","year":"2019","unstructured":"Choi JW, Moon WJ. Gadolinium deposition in the brain: current updates. Korean J Radiol. 2019, 20:134-47. 10.3348\/kjr.2018.0356","journal-title":"Korean J Radiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(17)30158-8","article-title":"Gadolinium deposition in the brain: summary of evidence and recommendations","volume":"16","author":"Gulani V","year":"2017","unstructured":"Gulani V, Calamante F, Shellock FG, Kanal E, Reeder SB. Gadolinium deposition in the brain: summary of evidence and recommendations. Lancet Neurol. 2017, 16:564-70. 10.1016\/S1474-4422(17)30158-8","journal-title":"Lancet Neurol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.13362","article-title":"Gadolinium retention after contrast-enhanced MRI","volume":"320","author":"Levine D","year":"2018","unstructured":"Levine D, McDonald RJ, Kressel HY. Gadolinium retention after contrast-enhanced MRI. JAMA. 2018, 320:1853-4. 10.1001\/jama.2018.13362","journal-title":"JAMA"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2021211401","article-title":"Gadolinium retention: what do we know?","volume":"301","author":"Cl\u00e9ment O","year":"2021","unstructured":"Cl\u00e9ment O. Gadolinium retention: what do we know?. Radiology. 2021, 301:643-4. 10.1148\/radiol.2021211401","journal-title":"Radiology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-018-0500-1","article-title":"Gadolinium-based contrast agent-related toxicities","volume":"32","author":"Pasquini L","year":"2018","unstructured":"Pasquini L, Napolitano A, Visconti E, Longo D, Romano A, Tom\u00e0 P, Rossi Espagnet MC. Gadolinium-based contrast agent-related toxicities. CNS Drugs. 2018, 32:229-40. 10.1007\/s40263-018-0500-1","journal-title":"CNS Drugs"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/120231-utility-of-gadolinium-use-in-the-imaging-follow-up-of-nonenhancing-primary-brain-neoplasms-in-children","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:49:32Z","timestamp":1707508172000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/120231-utility-of-gadolinium-use-in-the-imaging-follow-up-of-nonenhancing-primary-brain-neoplasms-in-children"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,15]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.31531","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11,15]]}}}